Stockreport

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth [Yahoo! Finance]

Design Therapeutics, Inc.  (DSGN) 
PDF lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Having said that, unprofitable companies are risky [Read more]